127 related articles for article (PubMed ID: 33940655)
21. Candidate single nucleotide polymorphisms and thromboembolism in acute lymphoblastic leukemia - A NOPHO ALL2008 study.
Jarvis KB; LeBlanc M; Tulstrup M; Nielsen RL; Albertsen BK; Gupta R; Huttunen P; Jónsson ÓG; Rank CU; Ranta S; Ruud E; Saks K; Trakymiene SS; Tuckuviene R; Schmiegelow K
Thromb Res; 2019 Dec; 184():92-98. PubMed ID: 31715544
[TBL] [Abstract][Full Text] [Related]
22. Replication of a genetic risk score for venous thromboembolism in whites but not in African Americans.
Folsom AR; Tang W; Weng LC; Roetker NS; Cushman M; Basu S; Pankow JS
J Thromb Haemost; 2016 Jan; 14(1):83-8. PubMed ID: 26565658
[TBL] [Abstract][Full Text] [Related]
23. The Risk of Incident Venous Thromboembolism Attributed to Overweight and Obesity: The Tromsø Study.
Frischmuth T; Tøndel BG; Brækkan SK; Hansen JB; Morelli VM
Thromb Haemost; 2024 Mar; 124(3):239-249. PubMed ID: 37549694
[TBL] [Abstract][Full Text] [Related]
24. Risk prediction of recurrent venous thromboembolism: a multiple genetic risk model.
Ahmad A; Sundquist K; Palmér K; Svensson PJ; Sundquist J; Memon AA
J Thromb Thrombolysis; 2019 Feb; 47(2):216-226. PubMed ID: 30368761
[TBL] [Abstract][Full Text] [Related]
25. Venous thromboembolism and subsequent permanent work-related disability.
Braekkan SK; Grosse SD; Okoroh EM; Tsai J; Cannegieter SC; Naess IA; Krokstad S; Hansen JB; Skjeldestad FE
J Thromb Haemost; 2016 Oct; 14(10):1978-1987. PubMed ID: 27411161
[TBL] [Abstract][Full Text] [Related]
26. Haplotypes of TAFI gene and the risk of cerebral venous thrombosis--a case-control study.
Orikaza CM; Morelli VM; Matos MF; Lourenço DM
Thromb Res; 2014 Jan; 133(1):120-4. PubMed ID: 24252537
[TBL] [Abstract][Full Text] [Related]
27. Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: The Tromsø Study.
Sejrup JK; Tøndel BG; Morelli VM; Løchen ML; Njølstad I; Mathiesen EB; Wilsgaard T; Hansen JB; Braekkan SK
J Thromb Haemost; 2022 Oct; 20(10):2342-2349. PubMed ID: 35815348
[TBL] [Abstract][Full Text] [Related]
28. Multilocus genetic risk scores for venous thromboembolism risk assessment.
Soria JM; Morange PE; Vila J; Souto JC; Moyano M; Trégouët DA; Mateo J; Saut N; Salas E; Elosua R
J Am Heart Assoc; 2014 Oct; 3(5):e001060. PubMed ID: 25341889
[TBL] [Abstract][Full Text] [Related]
29. Joint effect of ischemic stroke and obesity on the risk of venous thromboembolism: the Tromsø Study.
Tøndel BG; Sejrup JK; Morelli VM; Løchen ML; Njølstad I; Mathiesen EB; Wilsgaard T; Hansen JB; Brækkan SK
Res Pract Thromb Haemost; 2024 Mar; 8(3):102392. PubMed ID: 38665865
[TBL] [Abstract][Full Text] [Related]
30. High microRNA-145 plasma levels are associated with decreased risk of future incident venous thromboembolism: the HUNT study.
Morelli VM; Snir O; Hindberg KD; Hveem K; Brækkan SK; Hansen JB
Blood; 2024 Apr; 143(17):1773-1781. PubMed ID: 38211336
[TBL] [Abstract][Full Text] [Related]
31. Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factors.
Bruzelius M; Bottai M; Sabater-Lleal M; Strawbridge RJ; Bergendal A; Silveira A; Sundström A; Kieler H; Hamsten A; Odeberg J
J Thromb Haemost; 2015 Feb; 13(2):219-27. PubMed ID: 25472531
[TBL] [Abstract][Full Text] [Related]
32. Single nucleotide polymorphisms and the risk of venous thrombosis: results from a Danish case-cohort study.
El-Galaly TC; Severinsen MT; Overvad K; Steffensen R; Vistisen AK; Tjønneland A; Kristensen SR
Br J Haematol; 2013 Mar; 160(6):838-41. PubMed ID: 23150947
[TBL] [Abstract][Full Text] [Related]
33. Genetic variations associated with recurrent venous thrombosis.
van Hylckama Vlieg A; Flinterman LE; Bare LA; Cannegieter SC; Reitsma PH; Arellano AR; Tong CH; Devlin JJ; Rosendaal FR
Circ Cardiovasc Genet; 2014 Dec; 7(6):806-13. PubMed ID: 25210051
[TBL] [Abstract][Full Text] [Related]
34. Genetic Analysis of Venous Thromboembolism in UK Biobank Identifies the ZFPM2 Locus and Implicates Obesity as a Causal Risk Factor.
Klarin D; Emdin CA; Natarajan P; Conrad MF; ; Kathiresan S
Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28373160
[TBL] [Abstract][Full Text] [Related]
35. Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism.
Heit JA; Cunningham JM; Petterson TM; Armasu SM; Rider DN; DE Andrade M
J Thromb Haemost; 2011 Jun; 9(6):1133-42. PubMed ID: 21463476
[TBL] [Abstract][Full Text] [Related]
36. Interactions of established risk factors and a GWAS-based genetic risk score on the risk of venous thromboembolism.
Crous-Bou M; De Vivo I; Camargo CA; Varraso R; Grodstein F; Jensen MK; Kraft P; Goldhaber SZ; Lindström S; Kabrhel C
Thromb Haemost; 2016 Sep; 116(4):705-13. PubMed ID: 27305932
[TBL] [Abstract][Full Text] [Related]
37. Elevated plasma levels of plasminogen activator inhibitor-1 are associated with risk of future incident venous thromboembolism.
Frischmuth T; Hindberg K; Aukrust P; Ueland T; Braekkan SK; Hansen JB; Morelli VM
J Thromb Haemost; 2022 Jul; 20(7):1618-1626. PubMed ID: 35289062
[TBL] [Abstract][Full Text] [Related]
38. Taller height as a risk factor for venous thromboembolism: a Mendelian randomization meta-analysis.
Roetker NS; Armasu SM; Pankow JS; Lutsey PL; Tang W; Rosenberg MA; Palmer TM; MacLehose RF; Heckbert SR; Cushman M; de Andrade M; Folsom AR
J Thromb Haemost; 2017 Jul; 15(7):1334-1343. PubMed ID: 28445597
[TBL] [Abstract][Full Text] [Related]
39. C-reactive protein, obesity, and the risk of arterial and venous thrombosis.
Horvei LD; Grimnes G; Hindberg K; Mathiesen EB; Njølstad I; Wilsgaard T; Brox J; Braekkan SK; Hansen JB
J Thromb Haemost; 2016 Aug; 14(8):1561-71. PubMed ID: 27208592
[TBL] [Abstract][Full Text] [Related]
40. Prospective study of γ' fibrinogen and incident venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE).
Folsom AR; Tang W; George KM; Heckbert SR; MacLehose RF; Cushman M; Pankow JS
Thromb Res; 2016 Mar; 139():44-9. PubMed ID: 26916295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
